A catastrophic failure in European fertility regulations has allowed a single sperm donor carrying a deadly cancer gene to father nearly 200 children across 14 countries, exposing massive gaps in international oversight that put countless families at risk.
Story Snapshot
- Single donor with cancer-causing TP53 gene mutation fathered 197 children across Europe over 17 years
- Children have 90% lifetime cancer risk; some have already died from multiple cancers at young ages
- European Sperm Bank failed to detect Li Fraumeni syndrome during screening in 2005
- National laws were violated as sperm was distributed to 67 clinics in 14 countries without proper limits
Deadly Genetic Mutation Spreads Across Continents
The European Sperm Bank distributed sperm from a donor carrying a mutated TP53 gene to 67 fertility clinics across 14 countries between 2005 and 2022. The mutation causes Li Fraumeni syndrome, giving affected individuals a devastating 90% chance of developing cancer during their lifetime.
Up to 20% of the donor’s sperm contained this lethal genetic defect, meaning any children conceived from affected samples carry the mutation in every cell of their body.
Cancer geneticist Clare Turnbull described the diagnosis as “dreadful” and “clearly devastating,” highlighting the lifelong burden families now face. The investigation revealed that some children have already developed multiple cancers, with several dying at extremely young ages.
Edwige Kasper from France’s Rouen University Hospital confirmed that affected children have developed two different cancers and some have died in early childhood.
Sperm from donor with cancer-causing gene was used to conceive almost 200 children https://t.co/o8LZs6ua5H
— BBC News (UK) (@BBCNews) December 10, 2025
Regulatory Failures Enable International Distribution
The donor passed all screening requirements when he became a sperm donor as a student in 2005, despite carrying the cancer-causing mutation from birth. This massive oversight exposes critical flaws in genetic screening protocols that failed to detect one of the most dangerous hereditary cancer syndromes.
The European Sperm Bank’s inadequate testing allowed a ticking genetic time bomb to spread across multiple countries for nearly two decades.
International coordination failures compounded the problem. While individual nations maintain domestic limits on donor usage, no international law restricts worldwide distribution of donor sperm.
This regulatory gap enabled the European Sperm Bank to circumvent national protections designed to prevent exactly this type of catastrophe.
Laws Violated as Families Pay the Price
The investigation uncovered clear violations of national regulations designed to protect families. In Belgium, where sperm from a single donor should be limited to six families maximum, 53 children were born to 38 different women using the affected donor’s sperm.
This represents a nearly nine-fold violation of Belgian law, demonstrating how profit motives override safety regulations in the fertility industry.
The discovery emerged only after doctors treating children with cancers linked to sperm donation raised concerns at the European Society of Human Genetics conference.
At that time, 23 children with the genetic mutation had been identified from 67 known offspring, with ten already diagnosed with cancer. Freedom of Information requests across multiple countries later revealed the true scope: at least 197 affected children, with more potentially undiscovered.
